| Literature DB >> 35539114 |
Yanqing Qiao1, Ying Liu1, Haixia Liu1, Yonghui Li1, Wei Long2, Junying Wang1, Xiaoyu Mu1, Jing Chen1, Haile Liu1, Xueting Bai1, Lingfang Liu1, Yuan-Ming Sun2, Qiang Liu2, Meili Guo3, Xiao-Dong Zhang1,4.
Abstract
Gold nanoclusters (NCs) have been widely used in bioimaging and cancer therapy due to their unique electronic structures and tunable luminescence. However, their weak fluorescence prevents potential biomedical application, and thus it is necessary to develop an effective route to enhance the fluorescence of gold NCs. In this work, we report the fluorescence enhancement of ultrasmall GSH-protected Au NCs by Zn atom doping. The fluorescence signal of Zn-doped Au NCs shows approximately 5-fold enhancement compared to pure Au NCs. Density functional theory (DFT) calculation shows that Zn doping can enhance the electronic states of the highest occupied molecular orbital (HOMO), leading to enhancement of visible optical transitions. In vitro experiments show that AuZn alloy NCs can enhance the cancer radiotherapy via producing reactive oxygen species (ROS) and don't cause significant cytotoxicity. In vivo imaging indicates AuZn alloy NCs have significant passive targeting capability with high tumor uptake. Moreover, nearly 80% of GSH-protected AuZn alloy NCs can be rapidly eliminated via urine excretion. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35539114 PMCID: PMC9078413 DOI: 10.1039/c7ra13072d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361
Fig. 1Optical characterization of Zn-doped Au NCs. (a) UV-vis absorption spectra of Au NCs with different Zn doping contents. (b and c) Fluorescence spectra (λex = 270 nm) of Zn-doped Au NCs, synthesized with different molar ratios of Zn-to-Au precursor. (d) Images of Au NCs and AuZn alloy NCs under UV light.
Fig. 2Structural characterization of GSH-protected AuZn alloy NCs. (a) HRTEM image; (b) size distribution obtained from HRTEM image with an average size of 1.84 nm. (c) MALDI TOF mass spectrum (positive mode) of GSH-protected AuZn alloy NCs. (d) FT-IR spectra obtained from pure GSH (black line) and GSH-protected AuZn alloy NCs (red line).
Fig. 3Fluorescence lifetime of (a) Au NCs and (b) AuZn alloy NCs.
Fig. 4TDDFT simulation of model cluster systems of a metal core and one ligand. (a) Optimized geometry of the model system: gold core +1 ligand (left) and gold core with zinc central replacement +1 ligand (right). The gold 13 core is taken from literature. (b) Simulated absorption spectra of Au NCs and AuZn NCs. (c) Simulated density of states which is created from the Kohn–Sham energy with broadening factor 0.05 eV. (d) Density responds for Au + Zn model excited at 427 nm which corresponds to the excitation peak.
Fig. 5Cytotoxicity and radiosensitizing effect of AuZn alloy NCs in vitro. (a) Cell viabilities of AuZn alloy NCs at doses from 0 to 480 μg mL−1 after 24 and 48 h. (b) Cell viabilities without and with AuZn alloy NCs under radiation doses of 0, 2, and 4 Gy. (c) Quantitative analysis of intracellular ROS levels. (d–f) Fluorescence images of intracellular ROS levels.
Fig. 6In vivo imaging, tumor uptake, renal clearance and biodistribution. (a) Fluorescence images in vivo. (b) Ex vivo fluorescence imaging of heart, liver, spleen, lung, kidney, testes, bladder and tumor. Fluorescence signal of the AuZn alloy NCs in tumor (c) and bladder (d) at different time points p.i. (e) Biodistribution of the mice treated with AuZn alloy NCs at after 48 h p.i.